Diagnostic Value of Procalcitonin on Early Postoperative Infection After Pediatric Cardiac Surgery

被引:41
作者
Li, Xia [1 ,2 ]
Wang, Xu [1 ,2 ]
Li, Shoujun [2 ,3 ]
Yan, Jun [1 ,2 ]
Li, Dan [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Dept Pediat Intens Care Unit, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Fuwai Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Peking Union Med Coll, Dept Surg, Pediat Cardiac Ctr,Natl Ctr Cardiovasc Dis, Beijing, Peoples R China
关键词
cardiac surgery; cardiopulmonary bypass; congenital heart disease; postoperative infection; procalcitonin; C-REACTIVE PROTEIN; SERUM PROCALCITONIN; SEPTIC SHOCK; SEPSIS; INTERLEUKIN-6; MARKER;
D O I
10.1097/PCC.0000000000001118
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: Assess the diagnostic value of serial monitoring of procalcitonin levels on early postoperative infection after pediatric cardiac surgery with cardiopulmonary bypass. Design: Prospective, observational study. Setting: A pediatric cardiac surgical ICU (PICU) and pediatric cardiac surgery department at Fuwai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College. Patients: Patients were 3 years old and below, underwent cardiac surgery involving cardiopulmonary bypass, the Aristotle Comprehensive Complexity score was 8 or higher and free from active preoperative infection or inflammatory disease. Interventions: Blood samples for measurement of procalcitonin, C-reactive protein, and WBC were taken before surgery and daily for 7 days in postoperative period. Clinical, laboratory, and imaging data were collected on enrollment. Procalcitonin, C-reactive protein, WBC levels, and procalcitonin variation were calculated and compared between those with and without infection. Measurements and Main Results: Two hundred and thirty-eight children were enrolled. Presence of infection within 7 days of surgery, length of intubation, and ICU stay were documented. Two independent experts in regard to the complete medical chart determined the final diagnosis of postoperative infection. Infection was diagnosed in 45 patients. Procalcitonin peaked on the first postoperative day. No differences were found on procalcitonin within 3 days after operation between the infected and the noninfected patients, and significant correlation was found between procalcitonin on postoperative days 1-3 and cardiopulmonary bypass duration. Serum procalcitonin concentration was always higher than 1.0 ng/mL within 7 days after surgery and/or procalcitonin variation between postoperative days 4 and 7 was positive in the infected patients. Best receiver operating characteristics curves area under the curve were obtained for procalcitonin and procalcitonin variation from postoperative days 5 to 7. WBC-and C-reactive protein-related receiver operating characteristics curves area under the curve revealed a very poor ability to predict infection. Logistic regression found that only procalcitonin on postoperative day 7 and PICU stay was independently correlated to the infection status. There was no significant correlation between the absolute value of procalcitonin and timing of infection. Conclusions: Procalcitonin was more accurate than C-reactive protein and WBC to predict early postoperative infection, but the diagnostic properties of procalcitonin could not be observed during the first 3 postoperative days due to the inflammatory process related to cardiopulmonary bypass. The dynamic change of procalcitonin is more important than the absolute value to predict postoperative infection. The maintenance of a high level (procalcitonin > 1.0 ng/mL) within 7 days after surgery and/or a second increase in procalcitonin between the fourth and the seventh postoperative day could be used as an indicator of postoperative infection. Continuous procalcitonin monitoring might help to discover infection earlier.
引用
收藏
页码:420 / 428
页数:9
相关论文
共 22 条
[1]   Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation [J].
Abraham, E ;
Matthay, MA ;
Dinarello, CA ;
Vincent, JL ;
Cohen, J ;
Opal, SM ;
Glauser, M ;
Parsons, P ;
Fisher, CJ ;
Repine, JE .
CRITICAL CARE MEDICINE, 2000, 28 (01) :232-235
[2]  
Al-Nawas B, 1996, Eur J Med Res, V1, P331
[3]   Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations [J].
Aouifi, A ;
Piriou, V ;
Blanc, P ;
Bouvier, H ;
Bastien, O ;
Chiari, P ;
Rousson, R ;
Evans, R ;
Lehot, JJ .
BRITISH JOURNAL OF ANAESTHESIA, 1999, 83 (04) :602-607
[4]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[5]   Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit [J].
Balci, C ;
Sungurtekin, H ;
Gürses, E ;
Sungurtekin, U ;
Kaptanoglu, B .
CRITICAL CARE, 2003, 7 (01) :85-90
[6]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[7]   Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections:: cluster-randomised, single-blinded intervention trial [J].
Christ-Crain, M ;
Jaccard-Stolz, D ;
Bingisser, R ;
Gencay, MM ;
Huber, PR ;
Tamm, M ;
Müller, B .
LANCET, 2004, 363 (9409) :600-607
[8]   Plasma procalcitonin and C-reactive protein in acute septic shock: Clinical and biological correlates [J].
Claeys, R ;
Vinken, S ;
Spapen, H ;
Elst, KV ;
Decochez, K ;
Huyghens, L ;
Gorus, FK .
CRITICAL CARE MEDICINE, 2002, 30 (04) :757-762
[9]  
Dörge H, 2003, THORAC CARDIOV SURG, V51, P322
[10]   Postoperative mediastinitis: Classification and management [J].
ElOakley, RM ;
Wright, JE .
ANNALS OF THORACIC SURGERY, 1996, 61 (03) :1030-1036